| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.8 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.9 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.0087 | 0.9 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.0086 | 0.9 |